| Literature DB >> 17426150 |
Michael G Malkowski1, Erin Quartley, Alan E Friedman, Julie Babulski, Yoshiko Kon, Jennifer Wolfley, Meriem Said, Joseph R Luft, Eric M Phizicky, George T DeTitta, Elizabeth J Grayhack.
Abstract
Saccharomyces cerevisiae is an ideal host from which to obtain high levels of posttranslationally modified eukaryotic proteins for x-ray crystallography. However, extensive replacement of methionine by selenomethionine for anomalous dispersion phasing has proven intractable in yeast. We report a general method to incorporate selenomethionine into proteins expressed in yeast based on manipulation of the appropriate metabolic pathways. sam1(-) sam2(-) mutants, in which the conversion of methionine to S-adenosylmethionine is blocked, exhibit reduced selenomethionine toxicity compared with wild-type yeast, increased production of protein during growth in selenomethionine, and efficient replacement of methionine by selenomethionine, based on quantitative mass spectrometry and x-ray crystallography. The structure of yeast tryptophanyl-tRNA synthetase was solved to 1.8 A by using multiwavelength anomalous dispersion phasing with protein that was expressed and purified from the sam1(-) sam2(-) strain grown in selenomethionine. Six of eight selenium residues were located in the structure.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17426150 PMCID: PMC1850019 DOI: 10.1073/pnas.0610337104
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205